| Cat. No. |
产品名 |
作用方式
|
纯度 |
是否罕见病
|
| HY-153179 |
Mal-Gly-PAB-Exatecan-D-glucuronic acid |
Inhibitor |
99.82% |
否 |
| HY-144004 |
DSPE-PEG2000-Mal ammonium |
|
≥95.0% |
否 |
| HY-145399 |
AZ14170133 |
Inhibitor |
98.95% |
否 |
| HY-126682 |
Mal-VC-PAB-DM1 |
|
99.41% |
否 |
| HY-147271 |
Mal-PEG8-Val-Ala-PAB-Exatecan |
Inhibitor |
99.48% |
否 |
| HY-126687 |
Mal-PEG4-VC-PAB-DMEA-PNU-159682 |
|
96.17% |
否 |
| HY-141156 |
Mal-PEG8-Val-Cit-PAB-MMAE |
|
99.67% |
否 |
| HY-139642 |
Mal-(CH2)5-Val-Cit-PAB-Eribulin |
|
99.82% |
否 |
| HY-128870 |
Mal-PEG2-VCP-Eribulin |
|
99.82% |
否 |
| HY-126505 |
Mal-PEG4-NHS ester |
|
99.39% |
否 |
| HY-126504 |
Mal-PEG2-NHS ester |
|
98.55% |
否 |
| HY-116683 |
116-9e |
Inhibitor |
98.55% |
否 |
| HY-126887 |
Mal-PEG8-NHS ester |
|
98.44% |
否 |
| HY-W441007 |
DSPE-Mal |
|
≥95.0% |
否 |
| HY-18593 |
Mal-β-CD |
|
≥98.0% |
否 |
| HY-153892 |
Gly-Mal-GGFG-Deruxtecan 2-hydroxypropanamide |
Inhibitor |
99.79% |
否 |
| HY-153795 |
Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan |
Inhibitor |
99.09% |
否 |
| HY-100567 |
MAL-di-EG-Val-Cit-PAB-MMAE |
|
98.04% |
否 |
| HY-133400 |
endo-BCN-PEG3-mal |
|
98.00% |
否 |
| HY-129526 |
Mal-PEG3-NHS ester |
|
99.45% |
否 |
| HY-130085 |
Mal-PEG6-NHS ester |
|
≥98.0% |
否 |
| HY-148425 |
Mal-amide-PEG8-Val-Ala-PAB-PNP |
|
99.60% |
否 |
| HY-D1261 |
Naph-EA-mal |
|
≥95.0% |
否 |
| HY-124805 |
MAL3-101 |
Inhibitor |
98.22% |
否 |
| HY-126886 |
Mal-PEG1-NHS ester |
|
99.63% |
否 |
| HY-W010764 |
Biotin-PEG2-Mal |
|
99.64% |
否 |
| HY-148380A |
Mal-PEG8-Phe-Lys-PAB-Exatecan TFA |
Inhibitor |
98.44% |
否 |
| HY-137882 |
Glucocorticoid receptor agonist-1 Ala-Ala-Mal |
Agonist |
99.94% |
否 |
| HY-126502 |
Mal-C2-NHS ester |
|
99.30% |
否 |
| HY-W040134 |
Mal-amido-PEG4-NHS ester |
|
99.18% |
否 |
| HY-126685 |
Mal-PEG4-VA-PBD |
|
86.57% |
否 |
| HY-140988 |
Mal-NH2 TFA |
|
≥97.0% |
否 |
| HY-144004A |
DSPE-PEG5000-Mal ammonium |
|
≥95.0% |
否 |
| HY-147095 |
Val-Ala-PABC-Exatecan |
Inhibitor |
99.90% |
否 |
| HY-41919 |
Mal-L-PA-NH-Boc |
|
99.30% |
否 |
| HY-42151 |
Mal-amido-PEG2-C2-acid |
|
99.58% |
否 |
| HY-W020780 |
mPEG-Mal (MW 5000) |
|
≥98.0% |
否 |
| HY-140691 |
m-PEG-mal (MW 10000) |
|
99.89% |
否 |
| HY-W040133 |
Mal-amido-PEG8-NHS ester |
|
99.23% |
否 |
| HY-W190796A |
Mal-PEG3-NH2 TFA |
|
99.07% |
否 |
| HY-126686 |
Mal-Phe-C4-VC-PAB-MMAE |
|
99.54% |
否 |
| HY-126961 |
Mal-PEG4-acid |
|
99.00% |
否 |
| HY-126963 |
Mal-PEG6-acid |
|
98.96% |
否 |
| HY-135048 |
Mal-PEG4-OH |
|
≥95.0% |
否 |
| HY-140145 |
Mal-PEG4-Val-Cit-PAB-PNP |
|
97.05% |
否 |
| HY-140907 |
Biotin-PEG3-Mal |
|
98.88% |
否 |
| HY-148436 |
Glucocorticoid receptor agonist-2 Ala-Ala-Mal |
|
98.99% |
否 |
| HY-160885A |
NH2-Gly-PAB-Exatecan-D-glucuronic acid formic |
|
99.34% |
否 |
| HY-D1390A |
Sulfo-Cy5-Mal |
|
92.91% |
否 |
| HY-132252 |
Mal-PEG8-Val-Ala-PABC |
|
99.06% |
否 |
| HY-126960 |
Mal-PEG1-acid |
|
99.40% |
否 |
| HY-130572 |
Azido-PEG5-acid |
|
≥98.0% |
否 |
| HY-140147 |
Mal-amido-PEG2-Val-Cit-PAB-PNP |
|
98.40% |
否 |
| HY-140689 |
m-PEG-mal (MW 2000) |
|
97.27% |
否 |
| HY-140909 |
Biotin-PEG11-Mal |
|
98.12% |
否 |
| HY-148461 |
Mal-VC-PAB-PNP |
|
96.86% |
否 |
| HY-W040289 |
Mal-amido-PEG2-NHS ester |
|
99.32% |
否 |
| HY-126688 |
Mal-C2-Gly3-EDA-PNU-159682 |
|
93.43% |
否 |
| HY-130426 |
Maleimido-tri(ethylene glycol)-propionic acid |
|
99.14% |
否 |
| HY-130442 |
Mal-PEG2-acid |
|
99.62% |
否 |
| HY-132989 |
Mal-Deferoxamine |
|
≥95.0% |
否 |
| HY-138395 |
DSPE-PEG6-Mal |
|
≥95.0% |
否 |
| HY-138430 |
Mal-PEG2-NHS |
|
≥95.0% |
否 |
| HY-140120 |
Mal-NH-ethyl-SS-propionic acid |
|
98.09% |
否 |
| HY-140140 |
PC Mal-NHS carbonate ester |
|
≥95.0% |
否 |
| HY-159072 |
Mal-Val-Ala-PAB-N(SO2Me)-Exatecan |
|
96.22% |
否 |
| HY-167036 |
DMG-PEG-Mal (MW 2000) |
|
99.31% |
否 |
| HY-B1376 |
Methsuximide |
|
99.68% |
否 |
| HY-W008879 |
Mal-amido-PEG6-NHS ester |
|
99.35% |
否 |
| HY-W018291 |
Mal-C6-amine TFA |
|
98.51% |
否 |
| HY-126683 |
Mal-C6-α-Amanitin |
|
98.48% |
否 |
| HY-101159 |
Mal-amido-PEG8-C2-acid |
|
99.04% |
否 |
| HY-130414 |
Mal-amido-PEG4-acid |
|
99.76% |
否 |
| HY-130944 |
Mal-PEG1-Val-Cit-PABC-OH |
|
95.01% |
否 |
| HY-135819 |
Mal-PEG24-NHS ester |
|
≥95.0% |
否 |
| HY-140037 |
Mal-PEG4-propargyl |
|
99.68% |
否 |
| HY-140963 |
Mal-PEG12-NHS ester |
|
96.99% |
否 |
| HY-148775B |
PLGA-PEG-MAL (20kDA-5.0kDA, LA:GA ratio 40:60) |
|
≥95.0% |
否 |
| HY-W440719 |
Cholesterol-PEG-MAL (MW 2000) |
|
95.07% |
否 |
| HY-147095A |
Val-Ala-PABC-Exatecan trifluoroacetate |
Inhibitor |
98.39% |
否 |
| HY-126506 |
Mal-PEG4-PFP ester |
|
95.40% |
否 |
| HY-126509 |
Mal-amido-PEG10-C2-NHS ester |
|
≥98.0% |
否 |
| HY-126888 |
Mal-PEG5-NHS ester |
|
99.04% |
否 |
| HY-130084 |
Mal-PEG2-VCP-NB |
|
98.25% |
否 |
| HY-130222 |
Mal-PEG2-Val-Cit-PAB-OH |
|
99.49% |
否 |
| HY-130334 |
Mal-PEG8-acid |
|
98.10% |
否 |
| HY-130454 |
Mal-PEG6-PFP ester |
|
96.18% |
否 |
| HY-138727 |
Mal-amido-PEG3-acid |
|
≥98.0% |
否 |
| HY-139726 |
Mal-PEG4-Val-Cit-PAB-MMAE |
|
98.64% |
否 |
| HY-140984 |
m-PEG24-Mal |
|
≥95.0% |
否 |
| HY-140991 |
Mal-NH-Boc |
|
≥97.0% |
否 |
| HY-140995 |
Bis-Mal-PEG11 |
|
97.25% |
否 |
| HY-145489 |
Mal-PEG2-Val-Cit-PABA |
|
98.91% |
否 |
| HY-148775 |
PLGA-PEG-MAL (60kDA-3.4kDA, LA:GA ratio 75:25) |
|
≥95.0% |
否 |
| HY-152121 |
Glucocorticoid receptor agonist-1 phosphate Ala-Ala-Mal |
Agonist |
95.21% |
否 |
| HY-156758 |
Mal-PEG8-Val-Cit-PAB-MMAF |
|
96.50% |
否 |
| HY-160897 |
Methoxy-PEG-C3-amide-C2-Mal |
|
99.69% |
否 |
| HY-164367 |
Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT |
|
98.19% |
否 |
| HY-166990A |
Methoxypolyethylene glycol maleimide (MW 10000) |
|
/ |
否 |
| HY-35261A |
Mal-PEG2-NH2 TFA |
|
99.22% |
否 |
| HY-130856 |
Mal-amido-PEG9-acid |
|
99.54% |
否 |
| HY-48692 |
Mal-EGGGG-PEG8-amide-bis(deoxyglucitol) |
|
99.89% |
否 |
| HY-126507 |
Mal-amido-PEG1-C2-NHS ester |
|
99.69% |
否 |
| HY-126672 |
Mal-PEG4-Val-Cit-PAB |
|
98.87% |
否 |
| HY-126684 |
Mal-PEG4-VC-PAB-DMEA-Seco-Duocarmycin SA |
|
/ |
否 |
| HY-126962 |
Mal-PEG5-acid |
|
99.12% |
否 |
| HY-128711 |
MAL-di-EG-Val-Cit-PAB-MMAF |
|
98.56% |
否 |
| HY-130141 |
m-PEG6-amino-Mal |
|
/ |
否 |
| HY-130232 |
Mal-amido-PEG2-TFP ester |
|
≥97.0% |
否 |
| HY-130469 |
Mal-PEG4-Boc |
|
99.93% |
否 |
| HY-130973 |
Mal-PEG4-bis-PEG4-propargyl |
|
/ |
否 |
| HY-132070 |
FA-PEG5-Mal |
|
99.46% |
否 |
| HY-133211 |
Mal-PEG6-Boc |
|
/ |
否 |
| HY-133454 |
Mal-PEG2-oxyamine |
|
≥95.0% |
否 |
| HY-133545 |
Mal-Ph-CONH-PEG4-NHS ester |
|
≥97.0% |
否 |
| HY-133581 |
Mal-PEG3-C1-NHS ester |
|
≥95.0% |
否 |
| HY-138522 |
NHS-bis-PEG2-amide-Mal |
|
/ |
否 |
| HY-138726 |
Mal-PEG10-NHS ester |
|
≥98.0% |
否 |
| HY-140143 |
Mal-PEG4-Val-Cit-PAB-OH |
|
96.92% |
否 |
| HY-140574 |
N-Mal-N-bis(PEG2-NH-Boc) |
|
≥96.0% |
否 |
| HY-140693 |
m-PEG-mal (MW 30000) |
|
≥98.0% |
否 |
| HY-140908 |
Biotin-PEG6-Mal |
|
98.96% |
否 |
| HY-140967 |
Mal-Amido-PEG4-Boc |
|
99.84% |
否 |
| HY-140975 |
Mal-amido-PEG24-acid |
|
98.51% |
否 |
| HY-140976A |
Mal-amido-PEG9-amine TFA |
|
99.37% |
否 |
| HY-140978 |
Mal-amido-PEG4-TFP ester |
|
99.32% |
否 |
| HY-141338 |
Lipoamide-PEG3-Mal |
|
99.61% |
否 |
| HY-148776 |
PLGA-PEG-MAL (20kDA-5.0kDA, LA:GA ratio 50:50) |
|
/ |
否 |
| HY-160178 |
Glucocorticoid receptor agonist-3 Ala-Ala-Mal |
|
99.72% |
否 |
| HY-160408 |
Mal-GGG-Bal-NHS ester |
|
97.60% |
否 |
| HY-164278 |
diABZI-V/C-Mal |
Agonist |
/ |
否 |
| HY-169322 |
APL-1081 |
Inhibitor |
/ |
否 |
| HY-170512 |
Mal-GGFG-PAB-MMAE |
|
99.96% |
否 |
| HY-23642 |
Mal-amido-(CH2COOH)2 |
|
99.15% |
否 |
| HY-35261 |
Mal-PEG2-NH2 |
|
/ |
否 |
| HY-NP0137 |
Maackia Amurensis Lectin I (Fluorescein) |
|
/ |
否 |
| HY-NP0181 |
Maackia Amurensis Lectin II (Biotinylated) |
|
/ |
否 |
| HY-W020780C |
mPEG-Mal (MW 3400) |
|
97.31% |
否 |
| HY-W800805 |
DOPE-Mal |
|
99.90% |
否 |
| HY-133454A |
Mal-PEG2-oxyamine TFA |
|
96.46% |
否 |
| HY-126692 |
Mal-VC-PAB-ABAEP-Azonafide |
|
/ |
否 |
| HY-131156 |
Mal-PEG2-Val-Cit-PABA-PNP |
|
96.82% |
否 |
| HY-148380 |
Mal-PEG8-Phe-Lys-PAB-Exatecan |
Inhibitor |
/ |
否 |
| HY-148812 |
Gly-Mal-Gly-Gly-Phe-Gly-amide-methylcyclopropane-Exatecan |
Inhibitor |
/ |
否 |
| HY-105844 |
Albutoin |
|
99.17% |
否 |
| HY-111121 |
cBu-Cit-OH |
|
/ |
否 |
| HY-123229 |
Ropizine |
|
/ |
否 |
| HY-126508 |
Mal-amido-PEG5-C2-NHS ester |
|
/ |
否 |
| HY-126668 |
Mal-PEG4-VC-PAB-DMEA |
|
/ |
否 |
| HY-126668A |
Mal-PEG4-VC-PAB-DMEA TFA |
|
/ |
否 |
| HY-126669 |
Mal-PEG4-VA |
|
/ |
否 |
| HY-126671 |
Mal-Phe-C4-Val-Cit-PAB |
|
/ |
否 |
| HY-126673 |
Mal-C2-Gly3-EDA |
|
/ |
否 |
| HY-126674 |
Mal-Phe-C4-Val-Cit-PAB-DMEA |
|
/ |
否 |
| HY-126689 |
Mal-Phe-C4-VC-PAB-DMEA-PNU-159682 |
|
/ |
否 |
| HY-130181 |
m-PEG4-amino-Mal |
|
/ |
否 |
| HY-130193 |
Mal-PEG2-NH-Boc |
|
/ |
否 |
| HY-130399 |
Mal-amido-PEG6-acid |
|
/ |
否 |
| HY-130416 |
Mal-PEG2-PFP ester |
|
/ |
否 |
| HY-130568 |
Mal-PEG1-PFP ester |
|
/ |
否 |
| HY-130586 |
Mal-PEG3-PFP ester |
|
/ |
否 |
| HY-130855 |
Mal-amido-PEG7-acid |
|
/ |
否 |
| HY-130860 |
Mal-NH-PEG2-CH2CH2COOPFP ester |
|
/ |
否 |
| HY-130861 |
Mal-NH-PEG4-CH2CH2COOPFP ester |
|
/ |
否 |
| HY-130953 |
Mal-PEG4-bis-PEG3-methyltetrazine |
|
/ |
否 |
| HY-130971 |
Mal-PEG4-bis-PEG3-DBCO |
|
/ |
否 |
| HY-133162 |
Mal-PEG1-Boc |
|
/ |
否 |
| HY-133210 |
Mal-PEG5-PFP ester |
|
/ |
否 |
| HY-133212 |
Mal-PEG8-Boc |
|
95.08% |
否 |
| HY-133389 |
Mal-PEG36-NHS ester |
|
/ |
否 |
| HY-133410 |
Mal-C2-cyclohexylcarboxyl-hydrazide TFA |
|
/ |
否 |
| HY-133410A |
Mal-C2-cyclohexylcarboxyl-hydrazide hydrochloride |
|
98.23% |
否 |
| HY-133459 |
Mal-PEG1-Val-Cit-OH |
|
/ |
否 |
| HY-133494 |
Folate-PEG1-mal |
|
/ |
否 |
| HY-133499 |
Boc-HyNic-PEG1-mal |
|
/ |
否 |
| HY-133503 |
Mal-amide-PEG2-oxyamine-Boc |
|
/ |
否 |
| HY-133544 |
Mal-CO-PEG5-NHS ester |
|
/ |
否 |
| HY-133574 |
Mal-amido-PEG3-C1-PFP ester |
|
/ |
否 |
| HY-133582 |
Mal-amido-PEG3-C1-NHS ester |
|
/ |
否 |
| HY-134684 |
Mal-PEG3-O-Ac |
|
/ |
否 |
| HY-134702 |
Mal-PEG12-CHO |
|
/ |
否 |
| HY-134745 |
DSPE-PEG2-mal |
|
/ |
否 |
| HY-135169 |
Mal-PEG3-Boc |
|
/ |
否 |
| HY-136060 |
Mal-PEG2-bis-PEG3-BCN |
|
/ |
否 |
| HY-136084 |
Mal-PEG4-(PEG3-DBCO)-(PEG3-TCO) |
|
/ |
否 |
| HY-136087 |
Mal-bis-PEG3-DBCO |
|
/ |
否 |
| HY-138375 |
Mal-PEG5-C2-NH2 hydrochloride |
|
/ |
否 |
| HY-138380 |
Mal-PEG4-C2-NH2 TFA |
|
98.60% |
否 |
| HY-138392 |
Mal-PEG25-NH2 hydrochloride |
|
/ |
否 |
| HY-138404 |
THP-PEG2-Mal |
|
/ |
否 |
| HY-138427 |
m-PEG18-Mal |
|
/ |
否 |
| HY-138428 |
m-PEG9-Mal |
|
/ |
否 |
| HY-138447 |
Mal-NH-PEG8-Boc |
|
98.37% |
否 |
| HY-138467 |
Mal-PFP ester |
|
/ |
否 |
| HY-138500 |
Mal-PEG12-NH-Boc |
|
/ |
否 |
| HY-138519 |
Bis-(Mal-PEG3)-PH-N-succinimidyl acetate |
|
/ |
否 |
| HY-138722 |
Mal-PEG10-Boc |
|
/ |
否 |
| HY-138723 |
Mal-PEG10-acid |
|
/ |
否 |
| HY-138728 |
Mal-amido-PEG5-acid |
|
/ |
否 |
| HY-138729 |
Mal-amido-PEG3-NHS ester |
|
/ |
否 |
| HY-138730 |
Mal-amido-PEG7-NHS ester |
|
/ |
否 |
| HY-138731 |
Mal-amido-PEG9-NHS ester |
|
/ |
否 |
| HY-138732 |
m-PEG5-amino-Mal |
|
/ |
否 |
| HY-139818 |
Mal-PEG-PLA (PEG MW 3000 & PLA MW 70,000) |
|
/ |
否 |
| HY-139856 |
Mal-Ala-Ala-PAB-PNP |
|
/ |
否 |
| HY-139956 |
Mal-amido-PEG9-Val-Ala-PAB-SG3200 |
|
/ |
否 |
| HY-139957 |
Mal-amido-PEG8-Val-Ala-PAB-SG3200 |
|
/ |
否 |
| HY-140144 |
Mal-PEG1-Val-Cit-PAB-PNP |
|
98.41% |
否 |
| HY-140146 |
Mal-amido-PEG2-Val-Cit-PAB-OH |
|
/ |
否 |
| HY-140306 |
Mal-Sulfo-DBCO |
|
/ |
否 |
| HY-140692 |
m-PEG-mal (MW 20000) |
|
/ |
否 |
| HY-140717 |
HO-PEG-mal (MW 3400) |
|
/ |
否 |
| HY-140718 |
HO-PEG-mal (MW 5000) |
|
/ |
否 |
| HY-140719 |
Mal-PEG-mal (MW 2000) |
|
/ |
否 |
| HY-140720 |
Mal-PEG-mal (MW 3400) |
|
/ |
否 |
| HY-140721 |
Mal-PEG-mal (MW 5000) |
|
/ |
否 |
| HY-140722 |
Mal-PEG-Succinimidyl Valerate (MW 20000) |
|
/ |
否 |
| HY-140956 |
DSPE-PEG8-Mal |
|
/ |
否 |
| HY-140962 |
Mal-PEG12-acid |
|
/ |
否 |
| HY-140965 |
Mal-PEG5-Boc |
|
/ |
否 |
| HY-140968 |
Mal-PEG2-alcohol |
|
99.67% |
否 |
| HY-140969 |
Mal-PEG3-alcohol |
|
/ |
否 |
| HY-140970 |
Mal-PEG8-alcohol |
|
/ |
否 |
| HY-140973 |
Mal-amido-PEG10-acid |
|
/ |
否 |
| HY-140976 |
Mal-amido-PEG9-amine |
|
/ |
否 |
| HY-140979 |
Mal-amido-PEG8-TFP ester |
|
/ |
否 |
| HY-140981 |
Mal-amido-PEG24-TFP ester |
|
/ |
否 |
| HY-140982 |
m-PEG8-Mal |
|
/ |
否 |
| HY-140983 |
m-PEG12-Mal |
|
/ |
否 |
| HY-140989 |
Mal-PEG1-bromide |
|
/ |
否 |
| HY-140993 |
Bis-Mal-PEG3 |
|
/ |
否 |
| HY-140994 |
Bis-Mal-PEG6 |
|
/ |
否 |
| HY-140999 |
Mal-PEG4-Lys(t-Boc)-NH-m-PEG24 |
|
/ |
否 |
| HY-141004 |
3,4-Dibromo-Mal-PEG2-amine |
|
/ |
否 |
| HY-141004A |
3,4-Dibromo-Mal-PEG2-amine TFA |
|
≥98.0% |
否 |
| HY-141009 |
N-(Mal-PEG6)-N-bis(PEG7-TCO) |
|
/ |
否 |
| HY-141076 |
N-(m-PEG4)-N'-(PEG3-Mal)-Cy5 |
|
/ |
否 |
| HY-141115 |
Mal-NO2-Ph-PEG12-NHS |
|
/ |
否 |
| HY-141146 |
Mal-amido-PEG8-val-gly-PAB-OH |
|
/ |
否 |
| HY-143841 |
Mal-amido-PEG15-acid |
|
/ |
否 |
| HY-143842 |
Mal-amido-PEG3-alcohol |
|
/ |
否 |
| HY-147231 |
SG3400 delate(Mal-amido-PEG8) |
|
/ |
否 |
| HY-148399 |
Mal-VC-PAB-PNP-CDN-A |
|
/ |
否 |
| HY-149416 |
Mal-PEG8-Val-Ala-PAB-SB-743921 |
|
/ |
否 |
| HY-151940 |
Mal-Pc |
Activator |
/ |
否 |
| HY-153067 |
Mal-cyclohexane-Gly-Gly-Phe-Gly-Exatecan |
Inhibitor |
/ |
否 |
| HY-154981 |
Mal-L-Dap(Boc)-OSu |
|
/ |
否 |
| HY-155901 |
Mal-NH-PEG-NH2 TFA (MW 2000) |
|
/ |
否 |
| HY-155902 |
Mal-PEG-OH (MW 5000) |
|
/ |
否 |
| HY-155902A |
Mal-PEG-OH (MW 2000) |
|
/ |
否 |
| HY-155902B |
Mal-PEG-OH (MW 1000) |
|
/ |
否 |
| HY-157919 |
Biotin-PEAC5-maleimide hydrochloride |
|
/ |
否 |
| HY-157920 |
Biotin-PE-maleimide |
|
/ |
否 |
| HY-158348 |
m-PEG8-Lys(Mal)-Val-Ala-PAB-Ph-CO-Dazostinag |
|
/ |
否 |
| HY-158349 |
Mal-Val-Ala-PAB-4-Abu(Me)-Dazostinag |
|
/ |
否 |
| HY-158351 |
Mal-Val-Ala-PAB-NMe-CH2CH2-O-CO-Dazostinag |
|
/ |
否 |
| HY-159184 |
THP-Mal |
|
/ |
否 |
| HY-159563 |
Mal-va-mac-SN38 |
|
/ |
否 |
| HY-160180 |
Glucocorticoid receptor agonist-4 Ala-Ala-Mal |
|
/ |
否 |
| HY-160702 |
DMBA-SIL-Mal-MMAE |
|
/ |
否 |
| HY-160885 |
NH2-Gly-PAB-Exatecan-D-glucuronic acid |
|
/ |
否 |
| HY-160981 |
Mal-PEG4-VCP-NB |
|
/ |
否 |
| HY-160982 |
Mal-PEG3-VCP-NB |
|
/ |
否 |
| HY-161244 |
FGA145 |
Inhibitor |
/ |
否 |
| HY-161245 |
FGA146 |
Inhibitor |
/ |
否 |
| HY-164705 |
Mal-Toxophore |
|
/ |
否 |
| HY-164706 |
m-PEG6-Lys-Mal-Toxophore-quinoline |
|
/ |
否 |
| HY-164785 |
TCO-PEG5-C2-Mal |
|
≥95.0% |
否 |
| HY-164829 |
Mal-C5-Gly-Gly-Phe-MMAE |
Inhibitor |
/ |
否 |
| HY-166651 |
DSPE-Hyd-PEG-Mal (MW 2000) |
|
/ |
否 |
| HY-166807 |
Palmitate-PEG-Mal (MW 1000) |
|
/ |
否 |
| HY-166990 |
Methoxypolyethylene glycol maleimide (MW 5000) |
|
99.94% |
否 |
| HY-166990B |
Methoxypolyethylene glycol maleimide (MW 2000) |
|
/ |
否 |
| HY-166990C |
Methoxypolyethylene glycol maleimide (MW 750) |
|
/ |
否 |
| HY-169323 |
APL-1091 |
|
/ |
否 |
| HY-169324 |
APL-1092 |
|
/ |
否 |
| HY-169352 |
Mal-Exo-EVC |
|
/ |
否 |
| HY-169353 |
Mal-Exo-EEVC |
|
/ |
否 |
| HY-171138 |
Mal-VC-PAB-DMEA-PNU-159682 |
Inhibitor |
/ |
否 |
| HY-D1390 |
Sulfo-Cy5-Mal potassium |
|
/ |
否 |
| HY-D2373 |
CY5.5-PEG2000-Mal |
|
/ |
否 |
| HY-D2374 |
CY5.5-PEG5000-Mal |
|
/ |
否 |
| HY-NP072 |
Maackia Amurensis Lectin I |
|
/ |
否 |
| HY-NP073 |
Maackia Amurensis Lectin II |
|
/ |
否 |
| HY-NP150 |
Maackia Amurensis Lectin I (Biotinylated) |
|
/ |
否 |
| HY-P4047 |
Cyclo(RGDfK(Mal)) |
|
/ |
否 |
| HY-RS07991 |
MAL Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
| HY-RS07992 |
MAL2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
否 |
| HY-W019794 |
Mal-PEG16-NHS ester |
|
/ |
否 |
| HY-W020780A |
mPEG-Mal (MW 350) |
|
/ |
否 |
| HY-W020780B |
mPEG-Mal (MW 750) |
|
/ |
否 |
| HY-W190796 |
Mal-PEG3-NH2 |
|
/ |
否 |
| HY-W416185 |
3,4,6-Tri-O-benzyl-α-D-galactopyranose 1,2-methyl orthoacetate |
|
/ |
否 |
| HY-W440718 |
Cholesterol-PEG-Mal (MW 1000) |
|
/ |
否 |
| HY-W440720 |
Cholesterol-PEG-Mal (MW 3400) |
|
/ |
否 |
| HY-W440721 |
Cholesterol-PEG-Mal (MW 5000) |
|
/ |
否 |
| HY-W440949 |
Stearic acid-PEG-Mal (MW 1000) |
|
/ |
否 |
| HY-W440950 |
Stearic acid-PEG-Mal, MW 2000 |
|
/ |
否 |
| HY-W440951 |
Stearic acid-PEG-Mal (MW 3400) |
|
/ |
否 |
| HY-W440952 |
Stearic acid-PEG-Mal (MW 5000) |
|
/ |
否 |
| HY-W440994 |
DOPE-PEG-Mal (MW 1000) |
|
/ |
否 |
| HY-W440995 |
DOPE-PEG-Mal (MW 2000) |
|
/ |
否 |
| HY-W440996 |
DOPE-PEG-Mal (MW 3400) |
|
/ |
否 |
| HY-W440997 |
DOPE-PEG-Mal (MW 5000) |
|
/ |
否 |
| HY-W877850 |
Mal-C5-N-bis(PEG2-C2-acid) |
|
96.25% |
否 |
| HY-130857 |
Mal-PEG24-acid |
|
/ |
否 |
| HY-130895 |
Bis-Mal-PEG5 |
|
/ |
否 |
| HY-140997 |
Mal-PEG4-Glu(OH)-NH-m-PEG24 |
|
/ |
否 |
| HY-151752 |
Mal-AMCHC-N-Propargylamide |
|
/ |
否 |
| HY-151771 |
DACN(Tos,Mal) |
|
/ |
否 |
| HY-155438 |
Mal-Cz |
|
/ |
否 |
| HY-164731 |
Mal-PEG12-DOTA |
|
/ |
否 |
| HY-171182 |
D3017 |
|
/ |
否 |
| HY-400878 |
Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Mal |
Agonist |
99.86% |
否 |
| HY-D2420 |
Biotin-PEG5-Mal |
|
/ |
否 |
| HY-N12931 |
Maackia amurensis Lectin (MAA/MAL II) |
|
/ |
否 |
| HY-N12931F |
Maackia amurensis Lectin (MAA/MAL II)-Biotinylated |
|
/ |
否 |
| HY-W352966 |
Mal-PEG2-CH2COOH |
|
/ |
否 |
